Join us Thursday 4/24 at 2pm Central Time, as we focus on the valuation range for Ford (F). Register here. HIDE

Sangamo BioSciences (SGMO)

Add to Watchlists
Create an Alert
14.02 -0.64  -4.37% NASDAQ Apr 23, 4:59PM BATS Real time Currency in USD
View Full Chart
SGMO Price Chart
View All Events

SGMO Events

Date Type Description
Feb 11 Misc Sangamo BioSciences, Inc. 4Q2013 Earning Conference Call
Feb 11 Earnings Sangamo BioSciences, Inc. 4Q2013 Earning Result. Estimate: -0.09.
Dec 07 Misc Sangamo Biosciences Announces Seven Data Presentations at the 2013 American Society of Hematology Annual Meeting
Nov 25 Misc Sangamo Biosciences Announces Presentation at the 25th Annual Piper Jaffray Healthcare Conference
Oct 23 Misc Sangamo Biosciences Announces Third Quarter 2013 Conference Call and Webcast
Oct 23 Earnings Q3 2013 Earnings. Estimate: -0.11.
Aug 27 Misc Sangamo Call to Discuss Acquisition of Ceregene, Inc.
Jul 24 Misc Sangamo Biosciences Announces Second Quarter 2013 Conference Call and Webcast
Jul 24 Earnings Sangamo BioSciences Announces Second Quarter 2013 Earnings Release. Estimate: -0.12.
Jul 02 Misc Sangamo Biosciences Announces Presentation at the 8th Annual Jmp Securities Healthcare Conference
View All Performance Charts

SGMO Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Sangamo BioSciences is up 36.65% over the last year vs S&P 500 Total Return up 22.59%, Actelion up 71.93%, and Biomarin Pharmaceutical down 10.38%.

Get Quote for

PDF Report for SGMO

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download SGMO Pro Report PDF

Portfolio Strategies Featuring SGMO

Did Sangamo BioSciences make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

SGMO Profile

  • Sector: Healthcare
  • Industry: Biotechnology
  • Headquarters Country: United States
  • Headquarters State/Province: California
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Biological Product (except Diagnostic) Manufacturing
  • NAICS Code: 325414
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Sangamo BioSciences, Inc., is a clinical stage biopharmaceutical company that engaged in the research, development and commercialization of engineered DNA-binding proteins for the development of novel therapeutic strategies for unmet medical needs.

Recent Quotes

Symbol Price Chg Chg % Market Cap
SGMO 14.02 -0.64 -4.37% 879.57M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.